Wednesday, Feb 7, 2024 · SEC filings
What the smart money revealed on Feb 7
628 insider filings came in. We hid 69 planned (10b5-1) sellers and 410 people whose filings were routine, like grants and tax withholding.
3 insiders at Alto Neuroscience (ANRO) bought $347K of stock
Roles: CEO, CFO, Chief Medical Officer. Several insiders buying in the same few days is rare.
Charter Communications (CHTR) President and CEO Christopher Winfrey bought $1.49M
5,050 shares on the open market. Not a grant or an option exercise.
NextEra Energy (NEE) Director Kirk Hachigian bought $1.12M
20,000 shares on the open market. Not a grant or an option exercise.
Virtu Financial (VIRT) CEO Douglas Cifu bought $810K
50,000 shares on the open market. Not a grant or an option exercise.
Princeton Bancorp (BPRN) Director Martin Tuchman bought $609K
19,000 shares on the open market. Not a grant or an option exercise. Their past buys: 7 of 9 checked quarters beat the typical stock 6 months later.
Stryker (SYK) Director Ronda Stryker sold $100M
Not marked as a planned 10b5-1 sale. Sold 7% of the shares they held directly. Still holds 3.66M shares.
Church & Dwight (CHD) President and CEO Matthew Farrell sold $27.6M
Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 112,719 shares directly.
Netflix (NFLX) CFO Spencer Neumann sold $319K
Not marked as a planned 10b5-1 sale. Sold every share held directly.
Show 37 more real buys
Show 87 more real sales
13F season
Holdings as of Dec 31, 2023 are due Feb 14
49 funds have filed so far. 40 filed for the quarter before.
Biggest real insider buys, Feb 1–7
Open-market buys by officers and directors, filed in the 7 days up to Feb 7.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.